IVF 'cell bank' plan criticised
By BBC News,
BBC News
| 10. 15. 2007
In theory, cells banked from one embryo could provide treatment for a sibling threatened by serious disease many decades later.
However, Lord Robert Winston said the scheme, unveiled at the American Society for Reproductive Medicine conference, preyed on parents' fears.
One stem cell expert said it was "too early" to justify storing the embryos.
Stem cells are the body's "master cells", capable of growing into a wide variety of different tissues, and many scientists believe that one day, they could be harnessed to fight diseases of old age such as Parkinson's and Alzheimer's.
One source of these is the human embryo, and most IVF cycles produce more embryos than can be implanted back into a woman, leaving unwanted embryos which are normally frozen for later use or discarded.
However, the science of stem cells is still at a fledgling stage, and stem cells derived from an embryo have never been successfully used to treat or cure human disease.
'Future investment'
The technique revealed at the conference involves harvesting and developing stem cells taken from frozen embryos.
California-based firm StemLifeLine claims...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Robyn Vinter, The Guardian | 11.09.2025
A man going by the name “Rod Kissme” claims to have “very strong sperm”. It may seem like an eccentric boast for a Facebook profile page, but then this is no mundane corner of the internet. The group where Rod...